Zhu, Kang https://orcid.org/0000-0003-2623-3331
Chatrin, Chatrin https://orcid.org/0000-0002-5666-3175
Suskiewicz, Marcin J https://orcid.org/0000-0002-3279-6571
Aucagne, Vincent https://orcid.org/0000-0002-2647-0188
Foster, Benjamin https://orcid.org/0000-0003-0670-2321
Kessler, Benedikt M https://orcid.org/0000-0002-8160-2446
Gibbs-Seymour, Ian https://orcid.org/0000-0002-6904-2642
Ahel, Dragana https://orcid.org/0000-0002-7042-156X
Ahel, Ivan https://orcid.org/0000-0002-9446-3756
Funding for this research was provided by:
Wellcome Trust (210634)
Wellcome Trust (223107)
Wellcome Trust (302632)
UKRI | Biotechnology and Biological Sciences Research Council (BB/R007195/1)
UKRI | Biotechnology and Biological Sciences Research Council (BB/W016613/1)
Ovarian Cancer Research Alliance (813369)
Oxford University Challenge Seed Fund (USCF 456)
Cancer Research UK (C35050/A22284)
Cancer Research UK (C62538/A24670)
Edward Penley Abraham Research Fund
EC | European Research Council (101078837)
la Ligue contre le Cancer
Oxford University Press John Fell Research Fund (0006091 and 0014766)
University of Oxford Medical Sciences Division Pump Priming Award (006353)
Article History
Received: 14 March 2024
Revised: 16 August 2024
Accepted: 20 August 2024
First Online: 6 September 2024
Disclosure and competing interests statement
: The authors declare no competing interests.